Search
for
Sort by
Research 30 of 1000+
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- LB1007 Systemic treatment with a KLK5 inhibitor shows efficacy in a murine model of Netherton syndrome
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- Successful treatment of refractory folliculitis decalvans with secukinumab
- Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab
- 496 Understanding the mechanism of action of secukinumab using lesional hidradenitis suppurativa skin organ culture
- Alopecia Areata: A Complex Cytokine Driven Disease
- Effects of dihydrotestosterone on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells in patients with ankylosing spondylitis
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- Sycosis Barbae Treated With Bimekizumab
- Case Report: Bimekizumab for dissecting cellulitis of the scalp
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study
- 269 Down-regulatory role of cholecystokinin on psoriatic epidermal inflammation
- Bacteria induce skin regeneration via IL-1β signaling
- IL-17a induces age-related olfactory dysfunction by impairing regeneration and promoting respiratory metaplasia in mice
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Ophiasis Alopecia Areata in a Patient With Spondyloarthritis on Secukinumab: A Case Report and Review of the Literature
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A novel therapeutic paradigm for patients with extensive alopecia areata